Pages that link to "Q39131201"

The following pages link to Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties (Q39131201):

Displaying 47 items.

• Serotonin-dopamine interactions in the nigrostriatal system (Q28330228) (← links)
• Peripheral and central muscarinic receptor affinity of psychotropic drugs (Q28331038) (← links)
• Citalopram in the treatment of depression and other potential uses in psychiatry (Q33677537) (← links)
• Antidepressants: past, present and future (Q34061082) (← links)
• Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas (Q36046813) (← links)
• Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro (Q39642024) (← links)
• Recent progress in the development of new antidepressant drugs (Q39671568) (← links)
• Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro (Q39865865) (← links)
• Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity (Q40088615) (← links)
• Hepatotoxicity of Citalopram in Rats and First-Pass Metabolism (Q40543771) (← links)
• 6 Non-Tricyclic Antidepressants (Q41209500) (← links)
• Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171 (Q41241787) (← links)
• Specific inhibition of hypothalamic self-stimulation by selective reuptake blockade of either 5-hydroxytryptamine or noradrenaline (Q41286891) (← links)
• Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). (Q41610792) (← links)
• Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin (Q42191443) (← links)
• Influence of Citalopram and Chlorimipramine on Uptake of 5-HT by Isolated Perfused Guinea Pig Lungs (Q44078572) (← links)
• The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM. (Q44176719) (← links)
• Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain (Q44195703) (← links)
• Preliminary studies of the kinetics of citalopram in man (Q44396225) (← links)
• In vivo measurement of the serotonin transporter with (S)-([18F]fluoromethyl)-(+)-McN5652. (Q44557834) (← links)
• Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium (Q44898091) (← links)
• Citalopram versus mianserin. A controlled, double-blind trial in depressed patients (Q45153074) (← links)
• Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant (Q46203982) (← links)
• Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A (Q48244784) (← links)
• Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice (Q48256441) (← links)
• Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients (Q48969775) (← links)
• Comparison of the pharmacological actions of desmethylclomipramine and clomipramine (Q49114027) (← links)
• The effects of the specific uptake inhibitor Lu 10–171 (Citalopram) upon brain indoleamine stores in the maturing mouse (Q49120506) (← links)
• Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study (Q49156929) (← links)
• Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels (Q51849603) (← links)
• Citalopram-induced Generalized Lipidosis in Rats (Q67290550) (← links)
• The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects (Q68748830) (← links)
• Simultaneous determination of citalopram, monodesmethylcitalopram and didesmethylcitalopram in plasma by high-performance liquid chromatography after column extraction (Q68843380) (← links)
• Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist (Q69372210) (← links)
• Determination of citalopram in plasma and brain tissue of the rat by high-performance liquid chromatography with ultraviolet detection (Q69652625) (← links)
• The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients (Q69834660) (← links)
• Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients (Q69976418) (← links)
• CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study) (Q70959019) (← links)
• Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice (Q71624841) (← links)
• Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection (Q72030189) (← links)
• Kinetics of citalopram in test animals; drug exposure in safety studies (Q72056212) (← links)
• Kinetics of citalopram in man; plasma levels in patients (Q72056215) (← links)
• Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant (Q72056218) (← links)
• Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail (Q72056219) (← links)
• The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice (Q72565501) (← links)
• Further evidence for negative feedback control of serotonin release in the central nervous system (Q72645228) (← links)
• Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat (Q73189971) (← links)